Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Product Liability Cases
Pharma
Amid flurry of settlements, J&J resolves Risperdal claims
J&J has settled roughly 9,000 liability claims in the U.S. surrounding its antipsychotic drug Risperdal for $800 million.
Kevin Dunleavy
Nov 1, 2021 10:45am
GlaxoSmithKline scores a big win in its Zofran litigation
Jun 2, 2021 10:25am
J&J scores as trial judge cuts $8B Risperdal verdict to $6.8M
Jan 21, 2020 10:39am
Merck Fosamax case gets another shot at preemption argument
May 21, 2019 12:08pm
Valsartan mess to spawn surge of lawsuits: Bloomberg
Apr 24, 2019 3:01pm
Bayer and J&J ink $775M deal to resolve 25,000 Xarelto cases
Mar 25, 2019 12:46pm
